Literature DB >> 7686813

Distribution of tenascin, cellular fibronectins and integrins in the normal, hyperplastic and neoplastic breast.

G K Koukoulis1, A A Howeedy, M Korhonen, I Virtanen, V E Gould.   

Abstract

We present immunolocalization data on tenascin (Ten), and extradomains A and B (EDA-, EDB-) and oncofetal (Onc-) isoforms of cellular fibronectin (cFn), and alpha 1-6 and alpha v and beta 1-4 integrin subunits on cryosections of normal human breast, the spectrum of fibrocystic disease (FCD), and benign and malignant breast neoplasms. Fetal breast ducts were surrounded by broad Ten bands; adult breast ducts and acini were encompassed by thin continuous rims. In FCD, Ten was detectable and was clearly enhanced around hyperplastic ducts. Fibroadenomas showed uneven Ten periductal reactions while in all carcinomas, the stroma showed extensive and strong reactions that were most intense at the tumors' invasive edge. EDA-cFn's distribution was similar to Ten's but the staining was stronger while EDB- and Onc-cFn were virtually restricted to fetal breasts and carcinomas. In the normal adult breast, alpha 1,2,3 and alpha 6, and B1 and beta 4 integrins were detected in myoepithelial cells; weaker staining was also noted in the basolateral aspect of luminal cells; this profile was retained--and at times enhanced--in FCD, fibroadenomas and in situ carcinomas in which myoepithelial elements were present. In carcinomas, particularly in those of high grade, integrins tended to be reduced. However, mucinous carcinomas showed enhanced expression and the emergence of alpha 5 integrin that was not in the normal repertory; also a subset of infiltrating lobular carcinomas showed prominent alpha 1 and alpha 6 and beta 1 and--rarely--beta 4 staining distributed in delicate cytoplasmic processes (kinetopodia). These data indicate that the complex cell-matrix and cell-cell interactions of the normal breast are slightly altered in hyperplastic processes and benign neoplasms whereas profound chances occur in carcinomas. The latter display enhanced Ten and EDA- and Onc-cFn expression in particular, while most integrins appear decreased. Notably, mucinous and some lobular carcinomas display enhancement of certain integrins. The conspicuous localization of integrins in kinetopodia may be significant in relation to the invasive behavior of lobular carcinomas.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7686813

Source DB:  PubMed          Journal:  J Submicrosc Cytol Pathol        ISSN: 1122-9497


  31 in total

1.  Breast cancer cell-derived matrix supports vascular morphogenesis.

Authors:  Abigail C Hielscher; Connie Qiu; Sharon Gerecht
Journal:  Am J Physiol Cell Physiol       Date:  2012-01-25       Impact factor: 4.249

Review 2.  Integrin function in breast carcinoma progression.

Authors:  L M Shaw
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-10       Impact factor: 2.673

Review 3.  Fibronectin in malignancy: Cancer-specific alterations, protumoral effects, and therapeutic implications.

Authors:  Jonathan W Rick; Ankush Chandra; Cecilia Dalle Ore; Alan T Nguyen; Garima Yagnik; Manish K Aghi
Journal:  Semin Oncol       Date:  2019-08-27       Impact factor: 4.929

Review 4.  Fibronectins, their fibrillogenesis, and in vivo functions.

Authors:  Jean E Schwarzbauer; Douglas W DeSimone
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-07-01       Impact factor: 10.005

5.  C-reactive protein binds to integrin α2 and Fcγ receptor I, leading to breast cell adhesion and breast cancer progression.

Authors:  E-S Kim; S Y Kim; M Koh; H-M Lee; K Kim; J Jung; H S Kim; W K Moon; S Hwang; A Moon
Journal:  Oncogene       Date:  2017-08-28       Impact factor: 9.867

6.  Artemisinin reduces human melanoma cell migration by down-regulating alpha V beta 3 integrin and reducing metalloproteinase 2 production.

Authors:  Elisabetta Buommino; Adone Baroni; Nunzia Canozo; Marcella Petrazzuolo; Rosario Nicoletti; Antonio Vozza; Maria Antonietta Tufano
Journal:  Invest New Drugs       Date:  2008-10-28       Impact factor: 3.850

7.  Fibronectin expression modulates mammary epithelial cell proliferation during acinar differentiation.

Authors:  Courtney M Williams; Adam J Engler; R Daniel Slone; Leontine L Galante; Jean E Schwarzbauer
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

Review 8.  Differentiation and cancer in the mammary gland: shedding light on an old dichotomy.

Authors:  O W Petersen; L Rønnov-Jessen; V M Weaver; M J Bissell
Journal:  Adv Cancer Res       Date:  1998       Impact factor: 6.242

9.  Matrix crosslinking forces tumor progression by enhancing integrin signaling.

Authors:  Kandice R Levental; Hongmei Yu; Laura Kass; Johnathon N Lakins; Mikala Egeblad; Janine T Erler; Sheri F T Fong; Katalin Csiszar; Amato Giaccia; Wolfgang Weninger; Mitsuo Yamauchi; David L Gasser; Valerie M Weaver
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

10.  Down-regulation of laminin-5 in breast carcinoma cells.

Authors:  K J Martin; C P Kwan; K Nagasaki; X Zhang; M J O'Hare; C M Kaelin; R E Burgeson; A B Pardee; R Sager
Journal:  Mol Med       Date:  1998-09       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.